HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas J Sayers Selected Research

Interleukin-27 (Interleukin 27)

4/2009Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas J Sayers Research Topics

Disease

33Neoplasms (Cancer)
12/2021 - 04/2002
11Renal Cell Carcinoma (Grawitz Tumor)
12/2021 - 03/2003
9Neoplasm Metastasis (Metastasis)
12/2015 - 01/2003
5Kidney Neoplasms (Kidney Cancer)
08/2006 - 04/2002
4Melanoma (Melanoma, Malignant)
12/2021 - 12/2015
3Breast Neoplasms (Breast Cancer)
01/2014 - 04/2010
3Graft vs Host Disease (Graft-Versus-Host Disease)
08/2008 - 05/2004
2Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2017
2Neuroblastoma
04/2009 - 05/2006
1Experimental Melanoma
01/2021
1Adenocarcinoma
01/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2015
1Sarcoma (Soft Tissue Sarcoma)
10/2014
1Multiple Myeloma
07/2010
1Esophageal Squamous Cell Carcinoma
06/2010
1Human Influenza (Influenza)
08/2009
1Hematologic Neoplasms (Hematological Malignancy)
08/2008
1Carcinogenesis
01/2006
1Colonic Neoplasms (Colon Cancer)
11/2005
1Lymphoma (Lymphomas)
06/2004
1Leukemia
05/2004
1Myeloid Leukemia (Leukemia, Myelocytic)
07/2003
1Aplastic Anemia (Anemia, Hypoplastic)
05/2003

Drug/Important Bio-Agent (IBA)

12LigandsIBA
01/2021 - 01/2003
11Bortezomib (Velcade)FDA Link
12/2015 - 07/2003
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2017 - 04/2002
6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2003
6Proteasome InhibitorsIBA
12/2015 - 05/2004
5Fas Ligand Protein (Fas Ligand)IBA
06/2014 - 04/2002
5PerforinIBA
08/2009 - 04/2002
5Proteasome Endopeptidase Complex (Proteasome)IBA
01/2008 - 05/2004
4CytokinesIBA
05/2012 - 11/2004
4TNF-Related Apoptosis-Inducing LigandIBA
07/2010 - 05/2005
3WithanolidesIBA
02/2017 - 01/2017
3AntibodiesIBA
08/2011 - 01/2003
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
07/2010 - 02/2004
3Interleukin-2 (IL2)IBA
04/2009 - 03/2003
2physachenolide CIBA
12/2021 - 01/2021
2Poly I-CIBA
12/2021 - 01/2021
2Antineoplastic Agents (Antineoplastics)IBA
02/2017 - 01/2006
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2015 - 08/2009
2AntigensIBA
12/2015 - 08/2009
2Death Domain ReceptorsIBA
10/2015 - 01/2003
2Peptides (Polypeptides)IBA
05/2012 - 08/2009
2Interleukin-12 (IL 12)IBA
05/2006 - 11/2004
1PolynucleotidesIBA
01/2021
1rocaglamideIBA
11/2018
1AndrogensIBA
01/2017
1Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2015
1Aldehyde DehydrogenaseIBA
10/2015
1pazopanibFDA Link
10/2014
1regorafenibIBA
10/2014
1Sorafenib (BAY 43-9006)FDA Link
10/2014
1Tyrosine Kinase InhibitorsIBA
10/2014
1Secretory Leukocyte Peptidase InhibitorIBA
01/2014
1Drug CombinationsIBA
10/2012
1CucurbitacinsIBA
01/2012
1Toll-Like Receptor AgonistsIBA
07/2010
1Hazardous Substances (Hazardous Materials)IBA
06/2010
1IsotopesIBA
06/2010
1Caspase 8 (Caspase-8)IBA
05/2010
1Viral HemagglutininsIBA
08/2009
1Interleukin-27 (Interleukin 27)IBA
04/2009
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2006
1NK Cell Lectin-Like Receptor Subfamily KIBA
08/2006
1Cycloheximide (Cicloheximide)IBA
05/2005
1LectinsIBA
11/2004
1InterleukinsIBA
11/2004
1Interleukin-18 (Interleukin 18)IBA
11/2004
1Granzymes (Granzyme)IBA
06/2004
1Monoclonal AntibodiesIBA
02/2004
1Fc Receptors (Fc Receptor)IBA
02/2004
1EnzymesIBA
01/2003

Therapy/Procedure

12Therapeutics
02/2017 - 01/2003
8Immunotherapy
12/2021 - 11/2004
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2008 - 05/2004
2Drug Therapy (Chemotherapy)
12/2021 - 10/2012
1Neoadjuvant Therapy
10/2014
1Aftercare (After-Treatment)
06/2014
1Radiotherapy
10/2012
1Homologous Transplantation
08/2008
1Transplantation
05/2003
1Biological Therapy
04/2002